These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 18637782)

  • 1. Feasibility of conducting a primary prevention trial of low-dose aspirin for major adverse cardiovascular events in older people in Australia: results from the ASPirin in Reducing Events in the Elderly (ASPREE) pilot study.
    Nelson MR; Reid CM; Ames DA; Beilin LJ; Donnan GA; Gibbs P; Johnston CI; Krum H; Storey E; Tonkin A; Wolfe R; Woods R; McNeil JJ
    Med J Aust; 2008 Jul; 189(2):105-9. PubMed ID: 18637782
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recruiting general practice patients for large clinical trials: lessons from the Aspirin in Reducing Events in the Elderly (ASPREE) study.
    Lockery JE; Collyer TA; Abhayaratna WP; Fitzgerald SM; McNeil JJ; Nelson MR; Orchard SG; Reid C; Stocks NP; Trevaks RE; Woods R
    Med J Aust; 2019 Mar; 210(4):168-173. PubMed ID: 30835844
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Study design of ASPirin in Reducing Events in the Elderly (ASPREE): a randomized, controlled trial.
    ASPREE Investigator Group
    Contemp Clin Trials; 2013 Nov; 36(2):555-64. PubMed ID: 24113028
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The PACE pilot study: 12-month results and implications for future primary prevention trials in the elderly. (Prevention with low-dose Aspirin of Cardiovascular disease in the Elderly).
    Silagy CA; McNeil JJ; Donnan GA; Tonkin AM; Worsam B; Campion K
    J Am Geriatr Soc; 1994 Jun; 42(6):643-7. PubMed ID: 8201151
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Daily Low-Dose Aspirin and Risk of Serious Falls and Fractures in Healthy Older People: A Substudy of the ASPREE Randomized Clinical Trial.
    Barker AL; Morello R; Thao LTP; Seeman E; Ward SA; Sanders KM; Cumming RG; Pasco JA; Ebeling PR; Woods RL; Wolfe R; Khosla S; Hussain SM; Ronaldson K; Newman AB; Williamson JD; McNeil JJ
    JAMA Intern Med; 2022 Dec; 182(12):1289-1297. PubMed ID: 36342703
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A randomised controlled trial of low-dose aspirin for the prevention of fractures in healthy older people: protocol for the ASPREE-Fracture substudy.
    Barker AL; McNeil JJ; Seeman E; Ward SA; Sanders KM; Khosla S; Cumming RG; Pasco JA; Bohensky MA; Ebeling PR; Woods RL; Lockery JE; Wolfe R; Talevski J;
    Inj Prev; 2016 Aug; 22(4):297-301. PubMed ID: 26002770
    [TBL] [Abstract][Full Text] [Related]  

  • 7. AspiriN To Inhibit SEPSIS (ANTISEPSIS) randomised controlled trial protocol.
    Eisen DP; Moore EM; Leder K; Lockery J; McBryde ES; McNeil JJ; Pilcher D; Wolfe R; Woods RL
    BMJ Open; 2017 Jan; 7(1):e013636. PubMed ID: 28110287
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Low-Dose Aspirin and Progression of Age-Related Hearing Loss: A Secondary Analysis of the ASPREE Randomized Clinical Trial.
    Clark DPQ; Zhou Z; Hussain SM; Tran C; Britt C; Storey E; Lowthian JA; Shah RC; Dillon H; Wolfe R; Woods RL; Rance G; McNeil JJ
    JAMA Netw Open; 2024 Jul; 7(7):e2424373. PubMed ID: 39052288
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of aspirin on deaths associated with sepsis in healthy older people (ANTISEPSIS): a randomised, double-blind, placebo-controlled primary prevention trial.
    Eisen DP; Leder K; Woods RL; Lockery JE; McGuinness SL; Wolfe R; Pilcher D; Moore EM; Shastry A; Nelson MR; Reid CM; McNeil JJ; McBryde ES
    Lancet Respir Med; 2021 Feb; 9(2):186-195. PubMed ID: 32950072
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Baseline Characteristics of Participants in the ASPREE (ASPirin in Reducing Events in the Elderly) Study.
    McNeil JJ; Woods RL; Nelson MR; Murray AM; Reid CM; Kirpach B; Storey E; Shah RC; Wolfe RS; Tonkin AM; Newman AB; Williamson JD; Lockery JE; Margolis KL; Ernst ME; Abhayaratna WP; Stocks N; Fitzgerald SM; Trevaks RE; Orchard SG; Beilin LJ; Donnan GA; Gibbs P; Johnston CI; Grimm RH;
    J Gerontol A Biol Sci Med Sci; 2017 Oct; 72(11):1586-1593. PubMed ID: 28329340
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The aspirin in reducing events in the elderly trial: Statistical analysis plan.
    Wolfe R; Murray AM; Woods RL; Kirpach B; Gilbertson D; Shah RC; Nelson MR; Reid CM; Ernst ME; Lockery J; Donnan GA; Williamson J; McNeil JJ
    Int J Stroke; 2018 Apr; 13(3):335-338. PubMed ID: 29111960
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of Low-Dose Aspirin on the Course of Age-Related Macular Degeneration: A Secondary Analysis of the ASPREE Randomized Clinical Trial.
    Robman LD; Wolfe R; Woods RL; Thao LTP; Makeyeva GA; Hodgson LAB; Lepham YA; Jachno K; Phung J; Maguire E; Luong H; Trevaks RE; Ward SA; Fitzgerald SM; Orchard SG; Lacaze P; Storey E; Abhayaratna WP; Nelson MR; Guymer RH; McNeil JJ
    JAMA Ophthalmol; 2024 Jul; 142(7):627-635. PubMed ID: 38780931
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cost-effective recruitment methods for a large randomised trial in people with diabetes: A Study of Cardiovascular Events iN Diabetes (ASCEND).
    Aung T; Haynes R; Barton J; Cox J; Murawska A; Murphy K; Lay M; Armitage J; Bowman L;
    Trials; 2016 Jun; 17(1):286. PubMed ID: 27296091
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rationale for a trial of low-dose aspirin for the primary prevention of major adverse cardiovascular events and vascular dementia in the elderly: Aspirin in Reducing Events in the Elderly (ASPREE).
    Nelson M; Reid C; Beilin L; Donnan G; Johnston C; Krum H; Storey E; Tonkin A; McNeil J;
    Drugs Aging; 2003; 20(12):897-903. PubMed ID: 14565783
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of Aspirin on Cardiovascular Events and Bleeding in the Healthy Elderly.
    McNeil JJ; Wolfe R; Woods RL; Tonkin AM; Donnan GA; Nelson MR; Reid CM; Lockery JE; Kirpach B; Storey E; Shah RC; Williamson JD; Margolis KL; Ernst ME; Abhayaratna WP; Stocks N; Fitzgerald SM; Orchard SG; Trevaks RE; Beilin LJ; Johnston CI; Ryan J; Radziszewska B; Jelinek M; Malik M; Eaton CB; Brauer D; Cloud G; Wood EM; Mahady SE; Satterfield S; Grimm R; Murray AM;
    N Engl J Med; 2018 Oct; 379(16):1509-1518. PubMed ID: 30221597
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Slowing the progression of age-related hearing loss: Rationale and study design of the ASPIRIN in HEARING, retinal vessels imaging and neurocognition in older generations (ASPREE-HEARING) trial.
    Lowthian JA; Britt CJ; Rance G; Lin FR; Woods RL; Wolfe R; Nelson MR; Dillon HA; Ward S; Reid CM; Lockery JE; Nguyen TT; McNeil JJ; Storey E;
    Contemp Clin Trials; 2016 Jan; 46():60-66. PubMed ID: 26611434
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Study of Neurocognitive Outcomes, Radiological and Retinal Effects of Aspirin in Sleep Apnoea- rationale and methodology of the SNORE-ASA study.
    Ward SA; Storey E; Woods RL; Hamilton GS; Kawasaki R; Janke AL; Naughton MT; O'Donoghue F; Wolfe R; Wong TY; Reid CM; Abhayaratna WP; Stocks N; Trevaks R; Fitzgerald S; Hodgson LAB; Robman L; Workman B; McNeil JJ;
    Contemp Clin Trials; 2018 Jan; 64():101-111. PubMed ID: 29097299
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Low-dose aspirin for primary prevention of cardiovascular events in Japanese patients 60 years or older with atherosclerotic risk factors: a randomized clinical trial.
    Ikeda Y; Shimada K; Teramoto T; Uchiyama S; Yamazaki T; Oikawa S; Sugawara M; Ando K; Murata M; Yokoyama K; Ishizuka N
    JAMA; 2014 Dec; 312(23):2510-20. PubMed ID: 25401325
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rationale for a primary prevention study using low-dose aspirin to prevent coronary and cerebrovascular disease in the elderly.
    Silagy CA; McNeil JJ; Bulpitt CJ; Donnan GA; Tonkin AM; Worsam B
    J Am Geriatr Soc; 1991 May; 39(5):484-91. PubMed ID: 2022800
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Major GI bleeding in older persons using aspirin: incidence and risk factors in the ASPREE randomised controlled trial.
    Mahady SE; Margolis KL; Chan A; Polekhina G; Woods RL; Wolfe R; Nelson MR; Lockery JE; Wood EM; Reid C; Ernst ME; Murray A; Thao L; McNeil JJ
    Gut; 2021 Apr; 70(4):717-724. PubMed ID: 32747412
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.